Hemoglobin Evaluation Reflexive Cascade
Ordering Recommendation
Optimal test for the initial and confirmatory diagnosis of any suspected hemoglobinopathy; includes staged hematopathologist interpretation with comprehensive report. Do not use for the follow-up of an individual with a known diagnosis. Inform the laboratory if patient has received gene therapy; test interpretation may be impacted in such cases. For example, certain gene therapies may impact the performance of this test and interpretation of this result; the presence or absence of variants, zygosity, and HBB gene copy number may not be determined in such cases. Inform the laboratory if patient has received gene therapy by submitting the patient history form linked below.
New York DOH Approval Status
Specimen Required
Lavender (K2EDTA) or pink (K2EDTA).
Transport 5mL whole blood in original tube. (Min: 3 mL) Also acceptable: whole blood in an ARUP standard transport tube.
Refrigerated. Separate specimens must be submitted when multiple tests are ordered.
Patient history form, including information from a recent CBC, is required for interpretation.
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable
Methodology
High Performance Liquid Chromatography (HPLC) / Capillary Electrophoresis / RBC Solubility / Polymerase Chain Reaction (PCR) / Fluorescence Resonance Energy Transfer (FRET) / Sequencing / Massively Parallel Sequencing
Performed
Sun-Sat
Reported
Varies
Reference Interval
| HPLC testing Age-Defined Normal Hemoglobin Reference Intervals |
|||||||
|---|---|---|---|---|---|---|---|
| Age |
Hb A Percent |
Hb A2 Percent |
Hb F Percent |
Hb S Percent |
Hb C Percent |
Hb E Percent |
Hb Other Percent |
| 0-1 month | 7.6-54.8 | 0.0-1.4 | 45.8-91.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| 2 months | 14.7-70.1 | 0.0-2.0 | 32.7-85.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| 3 months | 26.6-81.8 | 0.1-2.6 | 14.5-73.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| 4 months | 43.0-89.5 | 0.8-3.0 | 4.2-56.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| 5 months | 60.8-94.0 | 1.5-3.3 | 1.0-38.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| 6-8 months | 78.2-96.6 | 1.8-3.5 | 0.9-19.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| 9-12 months | 86.1-97.2 | 1.9-3.5 | 0.6-11.6 | 0.0 | 0.0 | 0.0 | 0.0 |
| 13-23 months | 85.1-97.7 | 1.9-3.5 | 0.0-8.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| 2 years and older | 95.0-97.9 | 2.0-3.5 | 0.0-2.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Interpretive Data
Laboratory Developed Test (LDT)
Note
The Hemoglobin Evaluation Reflexive Cascade begins with HPLC analysis. If an abnormal hemoglobin is detected or if the CBC data is suggestive of a hemoglobinopathy, appropriate testing will be performed at an additional charge. Depending on findings, one or more reflexive tests may be required in order to provide a clinical interpretation. Tests added may include electrophoresis, solubility testing, mutational analysis and/or sequencing.
Quantitation of hemoglobin by HPLC or electrophoresis is most definitive in individuals one year of age and older. If quantitation of hemoglobin was performed before one year of age, repeat testing is recommended. Abnormal hemoglobin variants may require additional testing, which increases TAT up to 21 days.
Hotline History
Hotline History
CPT Codes
83021. If reflexed additional CPT codes may apply; refer to the reflexed test code for applicable codes.
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0050295 | Hemoglobin A | 4547-6 |
| 0050300 | Hemoglobin A2 | 4551-8 |
| 0050305 | Hemoglobin C | 4563-3 |
| 0050310 | Hemoglobin E | 4575-7 |
| 0050315 | Hemoglobin F | 4576-5 |
| 0050320 | Hemoglobin - Other | 48343-8 |
| 0050325 | Hemoglobin S | 4625-0 |
| 0050611 | Hemoglobin Evaluation | 21026-0 |
| 0081270 | Sickle Cell Solubility | 6864-3 |
| 2005800 | Beta Globin Full Gene Sequencing | |
| 2005802 | Alpha Thalassemia HBA1 and HBA2 Seq | |
| 2005805 | Hemoglobin Cascade Interpretation | 50398-7 |
| 2008793 | Hemoglobin, Capillary Electrophoresis | 13514-5 |
| 2010236 | Beta Globin (HBB) Del/Dup Result | |
| 2011645 | Alpha Globin (HBA1 and HBA2) Del/Dup Rst | |
| 3003512 | Gamma Globin (HBG1 and HBG2) Sequencing | 95795-1 |
Aliases
- A2 Hemoglobin
- Alpha Globin (HBA1 and HBA2) Sequencing
- Alpha Globin Variant
- Alpha Thalassemia (HBA1 &HBA2) 7
- Barts Hemoglobin
- Beta Globin (HBB) Sequencing and Deletion/Duplicaton
- Beta Globin Variant
- Beta-Thalassemia
- Fetal Hemoglobin
- fetaldex (Hemoglobin F)
- Gamma Globin (HBG1 and HBG2) Sequencing
- Hemoglobin A2
- Hemoglobin Cascade
- Hemoglobin Electrophoresis Cascade Level 1
- Hemoglobin F
- Hemoglobin Mass Spec Stud
- Sickle Cell Solubility
















